[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @Biopharma_Watch BiopharmaWatch BiopharmaWatch posts on X about $kura, $adct, $4151t, $2503t the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1734221906151165952/interactions)  - X Week XXXXX -XX% - X Month XXXXXX -XX% - X Months XXXXXXX +55% - X Year XXXXXXX +327% ### Mentions: XX [#](/creator/twitter::1734221906151165952/posts_active)  - X Week XX -XX% - X Month XXX -XX% - X Months XXXXX +333% - X Year XXXXX +2,298% ### Followers: XXXXX [#](/creator/twitter::1734221906151165952/followers)  - X Week XXXXX +1.20% - X Month XXXXX +4.70% - X Months XXXXX +62% - X Year XXXXX +116% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1734221906151165952/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) XXX% [finance](/list/finance) XXX% [cryptocurrencies](/list/cryptocurrencies) XXXX% **Social topic influence** [$kura](/topic/$kura) #7, [$adct](/topic/$adct) #11, [$4151t](/topic/$4151t) #1, [$2503t](/topic/$2503t) #63, [virtual](/topic/virtual) 3.06%, [$abos](/topic/$abos) 3.06%, [$tara](/topic/$tara) #44, [$asbp](/topic/$asbp) #7, [$biib](/topic/$biib) 1.02%, [ash](/topic/ash) #1360 **Top accounts mentioned or mentioned by** [@maximusholla](/creator/undefined) [@monacobiotech](/creator/undefined) [@boudin420](/creator/undefined) [@martinshkreli](/creator/undefined) [@biostocks](/creator/undefined) [@yaireinhorn](/creator/undefined) [@amaymd](/creator/undefined) [@biotech2k1](/creator/undefined) **Top assets mentioned** [ADC Therapeutics SA (ADCT)](/topic/$adct) [Taraxa (TARA)](/topic/$tara) [Biogen Inc (BIIB)](/topic/$biib) [Pacific Biosciences of California, Inc. (PACB)](/topic/$pacb) [Arrowhead Research Corporation (ARWR)](/topic/$arwr) [Terns Pharmaceuticals, Inc. Common Stock (TERN)](/topic/$tern) [apM Coin (APM)](/topic/$apm) [Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX)](/topic/$rxrx) ### Top Social Posts Top posts by engagements in the last XX hours "$KURA 11.96$ XXXX% 2025-12-02T13:02:00.000Z First U.S. Commercial Sale of KOMZIFTI Triggers $XXX Million Milestone Payment to Kura Oncology Under Collaboration and License Agreement with Kyowa Kirin" [X Link](https://x.com/Biopharma_Watch/status/1996606694898749905) 2025-12-04T15:45Z 1226 followers, XXX engagements "$BIIB Catalyst Date - 2025-12-05 Drug - Zorevunersen (investigational antisense oligonucleotide) Treatment - Dravet syndrome" [X Link](https://x.com/Biopharma_Watch/status/1996969071439761573) 2025-12-05T15:45Z 1226 followers, XX engagements "$KURA 11.96$ XXXX% 2025-12-03T13:32:00.000Z Kura Oncology to Host Virtual Investor Event to Discuss Data Presented at ASH 2025 on Triplet Combination of Ziftomenib (KOMZIFTI) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory Acute Myeloid" [X Link](https://x.com/Biopharma_Watch/status/1996969079727706511) 2025-12-05T15:45Z 1226 followers, XXX engagements "Biotech isnt dead. It just needed better tools. BiopharmaWatch cloned what specialist biotech hedge funds hold split it into X risk levels and ran it from Q2 XX Q2 XX. In that period $1M would have grown to as much as $2.33M. Heres how each portfolio behaves 👇 Would love to have your input/feedback on this @Maximus_Holla @monaco_biotech @boudin420 @MartinShkreli @BioStocks @yaireinhorn @A_May_MD @Biotech2k1" [X Link](https://x.com/Biopharma_Watch/status/1997810306051936724) 2025-12-07T23:27Z 1226 followers, XXX engagements "$RLMD Catalyst Date - 2025-12-04 Drug - NDV-01 (sustained release intravesical formulation of gemcitabine/docetaxel) Treatment - non-muscle invasive bladder cancer (NMIBC)" [X Link](https://x.com/Biopharma_Watch/status/1996606694525448412) 2025-12-04T15:45Z 1226 followers, XX engagements "Top Market Movers: Positive News Full Access: $GLMD 1.02$ XXXX% 2025-12-08T13:30:00.000Z Galmed Announces Acceptance of a Late-Breaking Abstract to be Presented at HEP-DART 2025 Meeting" [X Link](https://x.com/Biopharma_Watch/status/1998056228124274949) 2025-12-08T15:45Z 1226 followers, XXX engagements "Latest catalysts: $CGEM Catalyst Date - 2025-12-08 Drug - CLN-049 (FLT3xCD3 bispecific T cell engager) Treatment - relapsed/refractory acute myeloid leukemia (r/r AML) myelodysplastic syndrome (MDS)" [X Link](https://x.com/Biopharma_Watch/status/1998056233463677086) 2025-12-08T15:45Z 1226 followers, XXX engagements "Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $IMRN - 972.5K - 21.1M - XXXXX $QCLS - 1.9M - 38.0M - XXXXX $CLNN - 204.9K - 2.8M - 13.85" [X Link](https://x.com/Biopharma_Watch/status/1998056234906460675) 2025-12-08T15:45Z 1226 followers, XXX engagements "Top Market Movers: Negative News Full Access: $QNTM 9.94$ -XXXXX% 2025-11-28T14:30:00.000Z REPEAT: Award-winning Investigative News Program W5 Airs Part X of 3-part Television Series on Alleged Stock Market Manipulation of Q" [X Link](https://x.com/Biopharma_Watch/status/1994432354232967177) 2025-11-28T15:45Z 1219 followers, XXX engagements "Latest catalysts: $KURA Catalyst Date - 2025-11-30 Drug - Ziftomenib (oral menin inhibitor) Treatment - Relapsed or refractory NPM1-mutated acute myeloid leukemia (AML)" [X Link](https://x.com/Biopharma_Watch/status/1994432354493051230) 2025-11-28T15:45Z 1219 followers, XXX engagements "$PACB 2.31$ -XXXX% 2025-11-28T14:05:00.000Z PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference" [X Link](https://x.com/Biopharma_Watch/status/1994432368976015839) 2025-11-28T15:45Z 1219 followers, XX engagements "Top Market Movers: Positive News Full Access: $ARWR 62.28$ XXXX% 2025-12-02T12:30:00.000Z Arrowhead Pharmaceuticals Receives FDA Breakthrough Therapy Designation for Plozasiran in Severe Hypertriglyceridemia" [X Link](https://x.com/Biopharma_Watch/status/1996244287949050173) 2025-12-03T15:45Z 1219 followers, XXX engagements "Top Market Movers: Positive News Full Access: $SVRA 6.37$ XXXX% 2025-12-02T13:05:00.000Z Savara and PARI Granted a European Patent Covering the Drug-Device Combination of MOLBREEVI* Delivered Via the Proprietary eFlow Nebul" [X Link](https://x.com/Biopharma_Watch/status/1996606676565368961) 2025-12-04T15:45Z 1219 followers, XXX engagements "$SCNI 1.08$ XXXX% 2025-12-02T13:50:00.000Z Scinai Reports Nine-Month 2025 Results as CDMO Growth Continues and NanoAbs Pipeline Advances" [X Link](https://x.com/Biopharma_Watch/status/1996606721230503952) 2025-12-04T15:45Z 1218 followers, XXX engagements "Top Market Movers: Positive News Full Access: $INTS 0.39$ XXXX% 2025-12-04T12:47:00.000Z Intensity Therapeutics Announces Two Presentations at the Upcoming 2025 San Antonio Breast Cancer Symposium" [X Link](https://x.com/Biopharma_Watch/status/1996969065232155001) 2025-12-05T15:45Z 1219 followers, XXX engagements "$ZLAB 22.11$ -XXXX% November XX 2025 Zai Lab Announces Third Quarter 2025 Financial Results and Recent Corporate Updates" [X Link](https://x.com/Biopharma_Watch/status/1986822241649340776) 2025-11-07T15:45Z 1224 followers, XX engagements "Top Market Movers: Positive News Full Access: $ADCT 4.39$ XXXX% 2025-12-01T21:05:00.000Z ADC Therapeutics Makes Grants to New Employees Under Inducement Plan" [X Link](https://x.com/Biopharma_Watch/status/1995881901463355800) 2025-12-02T15:45Z 1226 followers, XXX engagements "Latest catalysts: $TLX Catalyst Date - 2025-12-02 Drug - TLX250-CDx (Zircaix189Zr-DFO-girentuximab) Treatment - indeterminate renal masses (IRMs)" [X Link](https://x.com/Biopharma_Watch/status/1995881906215465048) 2025-12-02T15:45Z 1226 followers, XXX engagements "$ABOS Catalyst Date - 2025-12-02 Drug - Sabirnetug (ACU193) Treatment - Alzheimer's disease" [X Link](https://x.com/Biopharma_Watch/status/1995881908321018115) 2025-12-02T15:45Z 1226 followers, XX engagements "$KURA 11.92$ XXXX% 2025-12-03T13:32:00.000Z Kura Oncology to Host Virtual Investor Event to Discuss Data Presented at ASH 2025 on Triplet Combination of Ziftomenib (KOMZIFTI) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory Acute Myeloid" [X Link](https://x.com/Biopharma_Watch/status/1996244288871784679) 2025-12-03T15:45Z 1226 followers, XXX engagements "Top Market Movers: Negative News Full Access: $ADCT 3.23$ -XXXXX% 2025-12-03T12:30:00.000Z ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA in Combination with Bispecific Antibody Sup" [X Link](https://x.com/Biopharma_Watch/status/1996244293036740617) 2025-12-03T15:45Z 1226 followers, XXX engagements "Latest catalysts: $TARA Catalyst Date - 2025-12-04 Drug - TARA-002 Treatment - Non-muscle invasive bladder cancer (NMIBC)" [X Link](https://x.com/Biopharma_Watch/status/1996244294328529312) 2025-12-03T15:45Z 1226 followers, XXX engagements "$ABOS Catalyst Date - 2025-12-04 Drug - Sabirnetug (ACU193) Treatment - Alzheimer's disease" [X Link](https://x.com/Biopharma_Watch/status/1996244295926612291) 2025-12-03T15:45Z 1226 followers, XX engagements "Top Market Movers: Negative News Full Access: $ADCT 3.13$ -XXXXX% 2025-12-03T12:30:00.000Z ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA in Combination with Bispecific Antibody Sup" [X Link](https://x.com/Biopharma_Watch/status/1996606680730361862) 2025-12-04T15:45Z 1226 followers, XXX engagements "Latest catalysts: $TARA Catalyst Date - 2025-12-04 Drug - TARA-002 Treatment - Non-muscle invasive bladder cancer (NMIBC)" [X Link](https://x.com/Biopharma_Watch/status/1996606681615372702) 2025-12-04T15:45Z 1226 followers, XXX engagements "$ASBP 0.09$ -XXXXX% 2025-12-03T00:00:00.000Z Aspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)" [X Link](https://x.com/Biopharma_Watch/status/1996606694693191737) 2025-12-04T15:45Z 1223 followers, XXX engagements "$ABOS Catalyst Date - 2025-12-04 Drug - Sabirnetug (ACU193) Treatment - Alzheimer's disease" [X Link](https://x.com/Biopharma_Watch/status/1996606704952418482) 2025-12-04T15:45Z 1226 followers, XX engagements "Top Market Movers: Negative News Full Access: $ADCT 3.13$ -XXXXX% 2025-12-03T12:30:00.000Z ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA in Combination with Bispecific Antibody Sup" [X Link](https://x.com/Biopharma_Watch/status/1996969069292278043) 2025-12-05T15:45Z 1226 followers, XXX engagements "Latest catalysts: $MNOV Catalyst Date - 2025-12-05 Drug - MN-166 (ibudilast) Treatment - Amyotrophic Lateral Sclerosis (ALS)" [X Link](https://x.com/Biopharma_Watch/status/1996969069363581432) 2025-12-05T15:45Z 1225 followers, XXX engagements "$ASBP 0.09$ -XXXXX% 2025-12-03T00:00:00.000Z Aspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)" [X Link](https://x.com/Biopharma_Watch/status/1996969085528350994) 2025-12-05T15:45Z 1223 followers, XXX engagements "$PRLD Catalyst Date - 2025-12-06 Drug - JAK2V617F mutant selective inhibitors Treatment - myeloproliferative neoplasms (MPNs)" [X Link](https://x.com/Biopharma_Watch/status/1996969113080725976) 2025-12-05T15:45Z 1225 followers, XXX engagements "Under the hood each sleeve holds 1525 names. Q2 XX forward returns by ticker 👇 A few winners drive a big part of the upside Losers hurt but position sizing stops them from killing the portfolio Its a stock-picker alpha inside a rules-based framework" [X Link](https://x.com/Biopharma_Watch/status/1997810732344524900) 2025-12-07T23:29Z 1223 followers, XX engagements "Not just YOLO oncology. Q2 XX therapeutic mix: Conservative HF: cardio + neuro + immunology + oncology Clinical Growth / High-Vol SMID: oncology & CNS heavy with rare disease spice Midcap Core: more endocrine ophthalmic infectious disease You can see where your risk really is" [X Link](https://x.com/Biopharma_Watch/status/1997810741479342170) 2025-12-07T23:29Z 1223 followers, XX engagements "$TERN Catalyst Date - 2025-12-08 Drug - TERN-701 (novel investigational allosteric BCR::ABL1 inhibitor) Treatment - chronic myeloid leukemia (CML)" [X Link](https://x.com/Biopharma_Watch/status/1998056278250467380) 2025-12-08T15:45Z 1226 followers, XXX engagements "$KURA 11.92$ XXXX% 2025-12-02T13:02:00.000Z First U.S. Commercial Sale of KOMZIFTI Triggers $XXX Million Milestone Payment to Kura Oncology Under Collaboration and License Agreement with Kyowa Kirin" [X Link](https://x.com/Biopharma_Watch/status/1996244305745526790) 2025-12-03T15:45Z 1226 followers, XXX engagements "$KURA 11.96$ XXXX% 2025-12-03T13:32:00.000Z Kura Oncology to Host Virtual Investor Event to Discuss Data Presented at ASH 2025 on Triplet Combination of Ziftomenib (KOMZIFTI) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory Acute Myeloid" [X Link](https://x.com/Biopharma_Watch/status/1996606677991432277) 2025-12-04T15:45Z 1226 followers, XXX engagements "$MDCX 1.72$ -XXXXX% 2025-12-08T00:00:00.000Z Medicus Pharma Ltd. Enters Into $XXX Million Warrant Inducement" [X Link](https://x.com/Biopharma_Watch/status/1998056235434918140) 2025-12-08T15:45Z 1226 followers, XX engagements "Top Market Movers: Negative News Full Access: $APM 1.69$ -XXXXX% October XX 2025 As part of the planned merger with DiamiR Biosciences Aptorum Group will expand its board and management team with seasoned executives" [X Link](https://x.com/Biopharma_Watch/status/1976675349451903424) 2025-10-10T15:45Z 1226 followers, XXX engagements "Top Market Movers: Negative News Full Access: $AEMD 3.65$ -XXXXX% 2025-12-08T00:00:00.000Z Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement Priced At-The-Market for Aggregate Gross Proceeds of" [X Link](https://x.com/Biopharma_Watch/status/1998056233249775832) 2025-12-08T15:45Z 1226 followers, XXX engagements "$RXRX 4.54$ XXXX% 2025-12-08T12:30:00.000Z Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at XX Weeks" [X Link](https://x.com/Biopharma_Watch/status/1998056241453773161) 2025-12-08T15:45Z 1226 followers, XXX engagements "Top Market Movers: Negative News Full Access: $HURA 1.27$ -XXXXX% 2025-12-08T12:50:00.000Z TuHURA Biosciences Presents Data Demonstrating the Delta Opioid Receptor (DOR) as a New Target in Overcoming Acquired Resistance to I" [X Link](https://x.com/Biopharma_Watch/status/1998418621840994341) 2025-12-09T15:45Z 1226 followers, XXX engagements "$KURA 11.03$ -XXXX% 2025-12-08T15:30:00.000Z Kura Oncology and Kyowa Kirin Report Combination Data for KOMZIFTI (Ziftomenib) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory AML" [X Link](https://x.com/Biopharma_Watch/status/1998418636642599159) 2025-12-09T15:45Z 1226 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Biopharma_Watch BiopharmaWatch
BiopharmaWatch posts on X about $kura, $adct, $4151t, $2503t the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX -XX%
- X Month XXXXXX -XX%
- X Months XXXXXXX +55%
- X Year XXXXXXX +327%
Mentions: XX #
- X Week XX -XX%
- X Month XXX -XX%
- X Months XXXXX +333%
- X Year XXXXX +2,298%
Followers: XXXXX #
- X Week XXXXX +1.20%
- X Month XXXXX +4.70%
- X Months XXXXX +62%
- X Year XXXXX +116%
CreatorRank: XXXXXXXXX #
Social Influence
Social category influence stocks XXX% finance XXX% cryptocurrencies XXXX%
Social topic influence $kura #7, $adct #11, $4151t #1, $2503t #63, virtual 3.06%, $abos 3.06%, $tara #44, $asbp #7, $biib 1.02%, ash #1360
Top accounts mentioned or mentioned by @maximusholla @monacobiotech @boudin420 @martinshkreli @biostocks @yaireinhorn @amaymd @biotech2k1
Top assets mentioned ADC Therapeutics SA (ADCT) Taraxa (TARA) Biogen Inc (BIIB) Pacific Biosciences of California, Inc. (PACB) Arrowhead Research Corporation (ARWR) Terns Pharmaceuticals, Inc. Common Stock (TERN) apM Coin (APM) Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX)
Top Social Posts
Top posts by engagements in the last XX hours
"$KURA 11.96$ XXXX% 2025-12-02T13:02:00.000Z First U.S. Commercial Sale of KOMZIFTI Triggers $XXX Million Milestone Payment to Kura Oncology Under Collaboration and License Agreement with Kyowa Kirin"
X Link 2025-12-04T15:45Z 1226 followers, XXX engagements
"$BIIB Catalyst Date - 2025-12-05 Drug - Zorevunersen (investigational antisense oligonucleotide) Treatment - Dravet syndrome"
X Link 2025-12-05T15:45Z 1226 followers, XX engagements
"$KURA 11.96$ XXXX% 2025-12-03T13:32:00.000Z Kura Oncology to Host Virtual Investor Event to Discuss Data Presented at ASH 2025 on Triplet Combination of Ziftomenib (KOMZIFTI) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory Acute Myeloid"
X Link 2025-12-05T15:45Z 1226 followers, XXX engagements
"Biotech isnt dead. It just needed better tools. BiopharmaWatch cloned what specialist biotech hedge funds hold split it into X risk levels and ran it from Q2 XX Q2 XX. In that period $1M would have grown to as much as $2.33M. Heres how each portfolio behaves 👇 Would love to have your input/feedback on this @Maximus_Holla @monaco_biotech @boudin420 @MartinShkreli @BioStocks @yaireinhorn @A_May_MD @Biotech2k1"
X Link 2025-12-07T23:27Z 1226 followers, XXX engagements
"$RLMD Catalyst Date - 2025-12-04 Drug - NDV-01 (sustained release intravesical formulation of gemcitabine/docetaxel) Treatment - non-muscle invasive bladder cancer (NMIBC)"
X Link 2025-12-04T15:45Z 1226 followers, XX engagements
"Top Market Movers: Positive News Full Access: $GLMD 1.02$ XXXX% 2025-12-08T13:30:00.000Z Galmed Announces Acceptance of a Late-Breaking Abstract to be Presented at HEP-DART 2025 Meeting"
X Link 2025-12-08T15:45Z 1226 followers, XXX engagements
"Latest catalysts: $CGEM Catalyst Date - 2025-12-08 Drug - CLN-049 (FLT3xCD3 bispecific T cell engager) Treatment - relapsed/refractory acute myeloid leukemia (r/r AML) myelodysplastic syndrome (MDS)"
X Link 2025-12-08T15:45Z 1226 followers, XXX engagements
"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $IMRN - 972.5K - 21.1M - XXXXX $QCLS - 1.9M - 38.0M - XXXXX $CLNN - 204.9K - 2.8M - 13.85"
X Link 2025-12-08T15:45Z 1226 followers, XXX engagements
"Top Market Movers: Negative News Full Access: $QNTM 9.94$ -XXXXX% 2025-11-28T14:30:00.000Z REPEAT: Award-winning Investigative News Program W5 Airs Part X of 3-part Television Series on Alleged Stock Market Manipulation of Q"
X Link 2025-11-28T15:45Z 1219 followers, XXX engagements
"Latest catalysts: $KURA Catalyst Date - 2025-11-30 Drug - Ziftomenib (oral menin inhibitor) Treatment - Relapsed or refractory NPM1-mutated acute myeloid leukemia (AML)"
X Link 2025-11-28T15:45Z 1219 followers, XXX engagements
"$PACB 2.31$ -XXXX% 2025-11-28T14:05:00.000Z PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference"
X Link 2025-11-28T15:45Z 1219 followers, XX engagements
"Top Market Movers: Positive News Full Access: $ARWR 62.28$ XXXX% 2025-12-02T12:30:00.000Z Arrowhead Pharmaceuticals Receives FDA Breakthrough Therapy Designation for Plozasiran in Severe Hypertriglyceridemia"
X Link 2025-12-03T15:45Z 1219 followers, XXX engagements
"Top Market Movers: Positive News Full Access: $SVRA 6.37$ XXXX% 2025-12-02T13:05:00.000Z Savara and PARI Granted a European Patent Covering the Drug-Device Combination of MOLBREEVI* Delivered Via the Proprietary eFlow Nebul"
X Link 2025-12-04T15:45Z 1219 followers, XXX engagements
"$SCNI 1.08$ XXXX% 2025-12-02T13:50:00.000Z Scinai Reports Nine-Month 2025 Results as CDMO Growth Continues and NanoAbs Pipeline Advances"
X Link 2025-12-04T15:45Z 1218 followers, XXX engagements
"Top Market Movers: Positive News Full Access: $INTS 0.39$ XXXX% 2025-12-04T12:47:00.000Z Intensity Therapeutics Announces Two Presentations at the Upcoming 2025 San Antonio Breast Cancer Symposium"
X Link 2025-12-05T15:45Z 1219 followers, XXX engagements
"$ZLAB 22.11$ -XXXX% November XX 2025 Zai Lab Announces Third Quarter 2025 Financial Results and Recent Corporate Updates"
X Link 2025-11-07T15:45Z 1224 followers, XX engagements
"Top Market Movers: Positive News Full Access: $ADCT 4.39$ XXXX% 2025-12-01T21:05:00.000Z ADC Therapeutics Makes Grants to New Employees Under Inducement Plan"
X Link 2025-12-02T15:45Z 1226 followers, XXX engagements
"Latest catalysts: $TLX Catalyst Date - 2025-12-02 Drug - TLX250-CDx (Zircaix189Zr-DFO-girentuximab) Treatment - indeterminate renal masses (IRMs)"
X Link 2025-12-02T15:45Z 1226 followers, XXX engagements
"$ABOS Catalyst Date - 2025-12-02 Drug - Sabirnetug (ACU193) Treatment - Alzheimer's disease"
X Link 2025-12-02T15:45Z 1226 followers, XX engagements
"$KURA 11.92$ XXXX% 2025-12-03T13:32:00.000Z Kura Oncology to Host Virtual Investor Event to Discuss Data Presented at ASH 2025 on Triplet Combination of Ziftomenib (KOMZIFTI) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory Acute Myeloid"
X Link 2025-12-03T15:45Z 1226 followers, XXX engagements
"Top Market Movers: Negative News Full Access: $ADCT 3.23$ -XXXXX% 2025-12-03T12:30:00.000Z ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA in Combination with Bispecific Antibody Sup"
X Link 2025-12-03T15:45Z 1226 followers, XXX engagements
"Latest catalysts: $TARA Catalyst Date - 2025-12-04 Drug - TARA-002 Treatment - Non-muscle invasive bladder cancer (NMIBC)"
X Link 2025-12-03T15:45Z 1226 followers, XXX engagements
"$ABOS Catalyst Date - 2025-12-04 Drug - Sabirnetug (ACU193) Treatment - Alzheimer's disease"
X Link 2025-12-03T15:45Z 1226 followers, XX engagements
"Top Market Movers: Negative News Full Access: $ADCT 3.13$ -XXXXX% 2025-12-03T12:30:00.000Z ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA in Combination with Bispecific Antibody Sup"
X Link 2025-12-04T15:45Z 1226 followers, XXX engagements
"Latest catalysts: $TARA Catalyst Date - 2025-12-04 Drug - TARA-002 Treatment - Non-muscle invasive bladder cancer (NMIBC)"
X Link 2025-12-04T15:45Z 1226 followers, XXX engagements
"$ASBP 0.09$ -XXXXX% 2025-12-03T00:00:00.000Z Aspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)"
X Link 2025-12-04T15:45Z 1223 followers, XXX engagements
"$ABOS Catalyst Date - 2025-12-04 Drug - Sabirnetug (ACU193) Treatment - Alzheimer's disease"
X Link 2025-12-04T15:45Z 1226 followers, XX engagements
"Top Market Movers: Negative News Full Access: $ADCT 3.13$ -XXXXX% 2025-12-03T12:30:00.000Z ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA in Combination with Bispecific Antibody Sup"
X Link 2025-12-05T15:45Z 1226 followers, XXX engagements
"Latest catalysts: $MNOV Catalyst Date - 2025-12-05 Drug - MN-166 (ibudilast) Treatment - Amyotrophic Lateral Sclerosis (ALS)"
X Link 2025-12-05T15:45Z 1225 followers, XXX engagements
"$ASBP 0.09$ -XXXXX% 2025-12-03T00:00:00.000Z Aspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)"
X Link 2025-12-05T15:45Z 1223 followers, XXX engagements
"$PRLD Catalyst Date - 2025-12-06 Drug - JAK2V617F mutant selective inhibitors Treatment - myeloproliferative neoplasms (MPNs)"
X Link 2025-12-05T15:45Z 1225 followers, XXX engagements
"Under the hood each sleeve holds 1525 names. Q2 XX forward returns by ticker 👇 A few winners drive a big part of the upside Losers hurt but position sizing stops them from killing the portfolio Its a stock-picker alpha inside a rules-based framework"
X Link 2025-12-07T23:29Z 1223 followers, XX engagements
"Not just YOLO oncology. Q2 XX therapeutic mix: Conservative HF: cardio + neuro + immunology + oncology Clinical Growth / High-Vol SMID: oncology & CNS heavy with rare disease spice Midcap Core: more endocrine ophthalmic infectious disease You can see where your risk really is"
X Link 2025-12-07T23:29Z 1223 followers, XX engagements
"$TERN Catalyst Date - 2025-12-08 Drug - TERN-701 (novel investigational allosteric BCR::ABL1 inhibitor) Treatment - chronic myeloid leukemia (CML)"
X Link 2025-12-08T15:45Z 1226 followers, XXX engagements
"$KURA 11.92$ XXXX% 2025-12-02T13:02:00.000Z First U.S. Commercial Sale of KOMZIFTI Triggers $XXX Million Milestone Payment to Kura Oncology Under Collaboration and License Agreement with Kyowa Kirin"
X Link 2025-12-03T15:45Z 1226 followers, XXX engagements
"$KURA 11.96$ XXXX% 2025-12-03T13:32:00.000Z Kura Oncology to Host Virtual Investor Event to Discuss Data Presented at ASH 2025 on Triplet Combination of Ziftomenib (KOMZIFTI) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory Acute Myeloid"
X Link 2025-12-04T15:45Z 1226 followers, XXX engagements
"$MDCX 1.72$ -XXXXX% 2025-12-08T00:00:00.000Z Medicus Pharma Ltd. Enters Into $XXX Million Warrant Inducement"
X Link 2025-12-08T15:45Z 1226 followers, XX engagements
"Top Market Movers: Negative News Full Access: $APM 1.69$ -XXXXX% October XX 2025 As part of the planned merger with DiamiR Biosciences Aptorum Group will expand its board and management team with seasoned executives"
X Link 2025-10-10T15:45Z 1226 followers, XXX engagements
"Top Market Movers: Negative News Full Access: $AEMD 3.65$ -XXXXX% 2025-12-08T00:00:00.000Z Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement Priced At-The-Market for Aggregate Gross Proceeds of"
X Link 2025-12-08T15:45Z 1226 followers, XXX engagements
"$RXRX 4.54$ XXXX% 2025-12-08T12:30:00.000Z Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at XX Weeks"
X Link 2025-12-08T15:45Z 1226 followers, XXX engagements
"Top Market Movers: Negative News Full Access: $HURA 1.27$ -XXXXX% 2025-12-08T12:50:00.000Z TuHURA Biosciences Presents Data Demonstrating the Delta Opioid Receptor (DOR) as a New Target in Overcoming Acquired Resistance to I"
X Link 2025-12-09T15:45Z 1226 followers, XXX engagements
"$KURA 11.03$ -XXXX% 2025-12-08T15:30:00.000Z Kura Oncology and Kyowa Kirin Report Combination Data for KOMZIFTI (Ziftomenib) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory AML"
X Link 2025-12-09T15:45Z 1226 followers, XXX engagements